The lack of overlap in their primary mechanisms of action suggests direct pharmacodynamic interactions are unlikely, but indirect effects through shared physiological pathways cannot be entirely excluded
There was no linear relationship between CL CR across groups (normal, mild, moderate, severe, and ESRD) and semaglutide exposure ( p = 0.127), or between CL CR across groups and semaglutide C max ( p = 0.164)
The triple agonist mechanism appears to match or slightly exceed tirzepatide for blood sugar management , likely because the glucagon component, while it can raise blood sugar in isolation, works synergistically with GLP-1 and GIP activation to produce a net positive effect on glucose regulation
Frias, MD , medical director and principal investigator at Velocity Clinical Research in Los Angeles, said during a presentation